Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Preparing for introduction of a dengue vaccine: Recommendations from the 1st Dengue v2V Asia-Pacific Meeting
Authors: Sai Kit Lam
Donald Burke
Maria Rosario Capeding
Chee Keong Chong
Laurent Coudeville
Jeremy Farrar
Duane Gubler
Sri Rezeki Hadinegoro
Jeffrey Hanna
Jean Lang
Han Lim Lee
Yee Sin Leo
Chan Quang Luong
Richard Mahoney
John Mcbride
Jorge Mendez-Galvan
Lee Ching Ng
Suchitra Nimmannitya
Eng Eong Ooi
Donald Shepard
Jaco Smit
Rémy Teyssou
Laurent Thomas
Joseph Torresi
Pedro Vasconcelos
Dewa Nyoman Wirawan
Sutee Yoksan
University of Malaya
University of Pittsburgh Graduate School of Public Health
Kementerian Kesihatan Malaysia
Sanofi Pasteur
University of Oxford
National University of Singapore
Ministry of Health, Republic of Indonesia
Tropical Population Health Unit
Institute for Medical Research Kuala Lumpur
Tan Tock Seng Hospital
Pasteur Institute in Ho Chi Minh City
International Vaccine Institute, Seoul
James Cook University, Australia
Hospital Infantil de Mexico Federico Gomez
National Environmental Authority
Thailand Ministry of Public Health
Brandeis University
Emergency Network at the University Hospital of Fort-de-France
Austin Center for Infection Research
Instituto Evandro Chagas
School of Public
Mahidol University
Keywords: Biochemistry, Genetics and Molecular Biology;Immunology and Microbiology;Medicine;Veterinary
Issue Date: 28-Nov-2011
Citation: Vaccine. Vol.29, No.51 (2011), 9417-9422
Abstract: Infection with dengue virus is a major public health problem in the Asia-Pacific region and throughout tropical and sub-tropical regions of the world. Vaccination represents a major opportunity to control dengue and several candidate vaccines are in development. Experts in dengue and in vaccine introduction gathered for a two day meeting during which they examined the challenges inherent to the introduction of a dengue vaccine into the national immunisation programmes of countries of the Asia-Pacific. The aim was to develop a series of recommendations to reduce the delay between vaccine licensure and vaccine introduction. Major recommendations arising from the meeting included: ascertaining and publicising the full burden and cost of dengue; changing the perception of dengue in non-endemic countries to help generate global support for dengue vaccination; ensuring high quality active surveillance systems and diagnostics; and identifying sustainable sources of funding, both to support vaccine introduction and to maintain the vaccination programme. The attendees at the meeting were in agreement that with the introduction of an effective vaccine, dengue is a disease that could be controlled, and that in order to ensure a vaccine is introduced as rapidly as possible, there is a need to start preparing now. © 2011 Elsevier Ltd.
ISSN: 18732518
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.